CCCC vs MS · rev $35.6M vs P/E 20, $344.27B cap
C4 Therapeutics Inc (CCCC) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
MS does not have a complete income-statement cache yet.
CCCC currently screens at market cap $425.7M. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the CCCC and MS stock pages for the full models.
Not investment advice.